What is LifeSignals?
Formerly known as HMicro Inc., LifeSignals specializes in the development of advanced semiconductor platforms designed to capture and transmit vital physiological data from both human and animal subjects. The company's core technology, the patented Life Signal Processor, serves as a foundational element for wireless medical devices, enabling seamless integration with cloud-based health monitoring systems. By focusing on high-fidelity data capture, LifeSignals addresses the growing demand for scalable, reliable, and cost-effective remote diagnostic solutions. The company operates at the intersection of hardware engineering and healthcare informatics, providing the essential silicon architecture that powers the next generation of wearable medical sensors and connected health devices.
How much funding has LifeSignals raised?
LifeSignals has raised a total of $16M across 3 funding rounds:
Series B
$5.5M
Series C
$10.2M
Debt
$320K
Series B (2014): $5.5M with participation from Seraph Group, XSeed Capital, and Reddy Capital
Series C (2016): $10.2M led by XSeed Capital, UniQuest, and Seraph Group
Debt (2021): $320K supported by PPP
Key Investors in LifeSignals
XSeed Capital
XSeed Capital is an early stage investment firm that partners with entrepreneurs aiming to create category-leading, high growth companies. The firm focuses on supporting innovative startups in their growth journey.
UniQuest
UniQuest is a leading university-based commercialisation company managing intellectual property and fostering the growth of research-driven startups.
Seraph Group
Seraph Group is a venture capital firm that provides strategic backing and operational expertise to technology-focused companies during their critical scaling phases.
What's next for LifeSignals?
With the recent influx of capital, LifeSignals is well-positioned to scale its manufacturing capabilities and expand its market reach within the global telehealth landscape. The company's strategic roadmap likely involves deepening its partnerships with enterprise-level healthcare providers and medical device manufacturers to integrate its processor technology into a broader array of clinical applications. As the industry shifts toward decentralized care models, LifeSignals' ability to provide secure, real-time data transmission will be pivotal. Future growth will likely focus on enhancing the interoperability of its semiconductor platform, ensuring that its technology remains the gold standard for high-performance, low-power vital sign monitoring in an increasingly connected medical environment.
See full LifeSignals company page
